MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
Open Access
- 18 February 2012
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 3 (2) , 195-202
Abstract
MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemiaKeywords
This publication has 36 references indexed in Scilit:
- NOTCH1 mutations in CLL associated with trisomy 12Blood, 2012
- miR-181b is a biomarker of disease progression in chronic lymphocytic leukemiaBlood, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemiaProceedings of the National Academy of Sciences, 2011
- MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia CellsPLOS ONE, 2011
- A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia PatientsPLOS ONE, 2010
- MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemiaMolecular Cancer, 2010
- Karyotype-specific microRNA signature in chronic lymphocytic leukemiaBlood, 2009
- MiRNAs and CancerThe American Journal of Pathology, 2009
- A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005